missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-12/IL-23 p40 Monomer Protein
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human IL-12 R beta 1 Fc Chimera (Catalog # 839-B1 ) is immobilized at 1 μg/mL (100 μL/well), the concentration of Recombinant Human IL-12/IL-23 p40 Monomer that produces 50% of the optimal binding response is 1-6 ng/mL.
Specifications
Specifications
| Accession Number | P29460 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Gene ID (Entrez) | 3593 |
| Molecular Weight (g/mol) | M.W. (Observed): 40 kDa, reducing conditions, M.W. (Theoretical): 34.7 kDa |
| Quantity | 10 μg |
| Source | Spodoptera frugiperda, Sf 21 (baculovirus)-derived human IL-12/IL-23 p40 protein Ile23-Ser328 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Alias | CLMF, CLMF p40, CLMF2, Cytotoxic lymphocyte maturation factor 40 kDa subunit, IL12 p40, IL-12 subunit p40, IL12B, IL-12B, IL-12BNK cell stimulatory factor chain 2, interleukin 12, p40, interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocytematuration factor 2, p40), interleukin-12 beta chain, interleukin-12 subunit beta, natural killer cell stimulatory factor, 40 kD subunit, NKSF, NKSF2, NKSF2IL12, subunit p40 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?